TS

Tim Starr

Chief Operating Officer at Regenity Biosciences

Tim Starr has a diverse and extensive work experience in the medical devices and pharmaceutical industries. Tim is currently working as the Chief Operating Officer at Collagen Matrix, Inc. Previously, they served as an Independent Advisor in Manufacturing & Quality Strategy at Tim Starr. Before that, they held the position of Vice President Operations for Medical Devices, Implantable Aortic Valves and Delivery Systems at Symetis SA. Tim also worked as the Vice President Operations at Boston Scientific and held various roles at Abbott Vascular, including Site Director for Medical Devices and Director of Quality & Compliance. Prior to Abbott Vascular, Tim Starr worked as the Director of Quality and Compliance at Boston Scientific. Tim started their career at Pfizer as the Quality Director for Pharmaceuticals and Infant Nutritionals and later took on the role of Quality Director at Wyeth Singapore Pte Ltd for Pharmaceuticals and Infant Nutritionals. Tim also served as the Quality Manager for Infant Nutritionals at Wyeth Nutritionals International and held the position of Quality Manager for Ingredients, Milk Powders, and consumer foods at Kerry Ingredients.

Tim Starr's education history is as follows:

From 1981 to 1983, Tim attended the Technology University of the Shannon, Athlone Campus, where they pursued a degree in Science with a focus on Biochemistry.

Next, from 1983 to 1984, Tim studied at the Galway-Mayo Institute of Technology, majoring in Science with a specialization in Fine Chemicals & Pharmaceutical Analysis.

Starting in 1985 and continuing until 1988, Tim enrolled in the Institute of Biology, London, completing the Membership of the Institute of Biology Examination. Their field of study was Biochemistry and Molecular Biology.

In 1994, Tim joined the University of Galway, where they pursued an Honours Degree in Science. Tim focused on Biochemistry and Molecular Biology during their time there until 1995.

From 1995 to 1996, Tim attended the Irish Management Institute, participating in the Diploma Executive Development Program. Their field of study during this program was Management/Professional Development.

Finally, in 2021, Tim became a Fellow of the Royal Society of Biology, specializing in Molecular Biology. The end year of their fellowship is not specified, suggesting that they are currently engaged in this educational pursuit.

Links

Timeline

  • Chief Operating Officer

    November, 2022 - present